BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer
about
BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
BRCAness as a Biomarker for Pr ...... Triple-Negative Breast Cancer
@ast
BRCAness as a Biomarker for Pr ...... Triple-Negative Breast Cancer
@en
type
label
BRCAness as a Biomarker for Pr ...... Triple-Negative Breast Cancer
@ast
BRCAness as a Biomarker for Pr ...... Triple-Negative Breast Cancer
@en
prefLabel
BRCAness as a Biomarker for Pr ...... Triple-Negative Breast Cancer
@ast
BRCAness as a Biomarker for Pr ...... Triple-Negative Breast Cancer
@en
P2093
P2860
P1433
P1476
BRCAness as a Biomarker for Pr ...... Triple-Negative Breast Cancer
@en
P2093
Junji Kishimoto
Mai Yamada
Makoto Kubo
Masafumi Nakamura
Masaya Kai
Masayuki Okido
Nobuyuki Arima
Reiki Nishimura
Takao Otsuka
Tetsuyuki Miyazaki
P2860
P304
P356
10.1371/JOURNAL.PONE.0167016
P407
P50
P577
2016-12-15T00:00:00Z